Market Summary
USD72.57+1.42
Market Closed2.00%
CVS Alerts
CVS Stock Price
CVS RSI Chart
CVS Valuation
CVS Price/Sales (Trailing)
CVS Profitability
CVS Fundamentals
CVS Revenue
CVS Earnings
Price Action
52 Week Range
64.62103.80
(Low)(High)
Last 7 days
0.4%
Last 30 days
7.2%
Last 90 days
2.2%
Trailing 12 Months
-28.3%
CVS Financial Health
CVS Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for CVS
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-08-31 | Mandadi Tilak | sold (taxes) | -850,664 | 65.17 | -13,053 | evp, chief technology officer |
2023-08-31 | Shah Prem S | sold (taxes) | -228,616 | 65.17 | -3,508 | evp and co-president of retail |
2023-08-03 | Clark James David | sold | -1,930,000 | 74.9247 | -25,759 | svp, cont & chief acct officer |
2023-05-18 | DEPARLE NANCY ANN | acquired | 99,598 | 69.31 | 1,437 | - |
2023-05-18 | Finucane Anne A. | acquired | 99,598 | 69.31 | 1,437 | - |
2023-05-18 | MILLON JEAN PIERRE | acquired | 99,598 | 69.31 | 1,437 | - |
2023-05-18 | AGUIRRE FERNANDO | acquired | 92,113 | 69.31 | 1,329 | - |
2023-05-18 | Balser Jeffrey R. | acquired | 92,113 | 69.31 | 1,329 | - |
2023-05-03 | Lynch Karen S | bought | 976,567 | 69.7548 | 14,000 | president and ceo |
2023-04-01 | Lynch Karen S | sold (taxes) | -6,961,140 | 74.31 | -93,677 | president and ceo |
Which funds bought or sold CVS recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-21 | Baystate Wealth Management LLC | added | 22.26 | 54,530 | 451,769 | 0.04% |
2023-09-21 | Jefferies Group LLC | reduced | -58.47 | -385,624 | 287,921 | -% |
2023-09-21 | Halpern Financial, Inc. | unchanged | - | -430 | 5,738 | -% |
2023-09-20 | BARCLAYS PLC | added | 97.8 | 173,058,000 | 379,052,000 | 0.24% |
2023-09-18 | CAPE ANN SAVINGS BANK | added | 1.49 | -37,531 | 634,752 | 0.42% |
2023-09-14 | IMS Capital Management | added | 2.77 | -30,354 | 660,952 | 0.37% |
2023-09-12 | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | sold off | -100 | -16,719,800 | - | -% |
2023-09-12 | DCM Advisors, LLC | reduced | -38.16 | -2,069,060 | 2,803,150 | 1.20% |
2023-09-12 | Farther Finance Advisors, LLC | reduced | -5.07 | -52,071 | 393,770 | 0.09% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 26,912,400 | 26,912,400 | 1.42% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
CVS Alerts
Schedule 13G FIlings of CVS Health
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 09, 2023 | vanguard group inc | 8.94% | 117,533,372 | SC 13G/A | |
| Feb 07, 2023 | blackrock inc. | 7.4% | 96,668,258 | SC 13G/A | |
| Feb 09, 2022 | vanguard group inc | 8.28% | 109,236,922 | SC 13G/A | |
| Feb 01, 2022 | blackrock inc. | 7.1% | 93,556,500 | SC 13G/A | |
| Feb 10, 2021 | vanguard group inc | 8.05% | 105,383,923 | SC 13G/A | |
| Jan 29, 2021 | blackrock inc. | 7.1% | 92,478,369 | SC 13G/A | |
| Feb 12, 2020 | vanguard group inc | 8.05% | 104,808,202 | SC 13G/A | |
| Feb 05, 2020 | blackrock inc. | 7.2% | 94,158,010 | SC 13G/A |
Recent SEC filings of CVS Health
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 21, 2023 | 8-K | Current Report | |
| Sep 11, 2023 | 8-K | Current Report | |
| Sep 08, 2023 | 3 | Insider Trading | |
| Sep 01, 2023 | 4 | Insider Trading | |
| Sep 01, 2023 | 4 | Insider Trading | |
| Aug 23, 2023 | 8-K | Current Report | |
| Aug 17, 2023 | 8-K | Current Report | |
| Aug 04, 2023 | 4 | Insider Trading | |
| Aug 04, 2023 | 13F-HR | Fund Holdings Report | |
| Aug 03, 2023 | 144 | Notice of Insider Sale Intent |
Peers (Alternatives to CVS Health)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
UNH | 473.0B | 348.5B | 3.40% | -1.54% | 22.41 | 1.36 | 13.69% | 15.63% |
CVS | 93.0B | 339.2B | 7.15% | -28.30% | 30.1 | 0.27 | 10.18% | -63.11% |
CI | 91.1B | 186.1B | 2.70% | 3.10% | 13.64 | 1.92 | 3.72% | 22.38% |
HUM | 65.7B | 98.7B | 2.62% | 0.03% | 23.41 | 0.71 | 10.45% | 7.48% |
CNC | 38.5B | 147.9B | 7.94% | -13.00% | 14.2 | 0.26 | 7.12% | 45.86% |
| MID-CAP | ||||||||
HQY | 6.3B | 937.9M | 8.26% | -1.16% | 491.91 | 6.73 | 17.97% | 120.64% |
OPCH | 6.1B | 4.1B | -5.40% | 9.61% | 25.5 | 1.48 | 11.23% | 37.01% |
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
PDCO | 2.8B | 6.5B | -13.00% | 16.88% | 13.3 | 0.44 | 1.83% | 10.70% |
| SMALL-CAP | ||||||||
RDNT | 1.9B | 1.5B | -12.60% | 56.43% | -148.05 | 1.25 | 12.20% | -155.34% |
ADUS | 1.4B | 999.1M | -5.28% | -6.03% | 26.12 | 1.41 | 10.42% | 21.37% |
BKD | 835.8M | 3.0B | 0.71% | -13.03% | -8.11 | 0.28 | 11.66% | -12.20% |
JYNT | 136.4M | 107.9M | -0.31% | -40.30% | 37.03 | 1.26 | 25.86% | -9.15% |
CVS Health News
Returns for CVS
Cumulative Returns on CVS
4.3%
10-Year Cumulative Returns
-1.0%
7-Year Cumulative Returns
0.1%
5-Year Cumulative Returns
9.0%
3-Year Cumulative Returns
Risks for CVS
What is the probability of a big loss on CVS?
58.1%
Probability that CVS Health stock will be more than 20% underwater in next one year
24.6%
Probability that CVS Health stock will be more than 30% underwater in next one year.
0%
Probability that CVS Health stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does CVS drawdown profile look like?
Y-axis is the maximum loss one would have experienced if CVS Health was unfortunately bought at previous high price.
Drawdowns
Financials for CVS Health
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 2.5% | 339,204 | 330,919 | 322,467 | 315,225 | 307,860 | 299,840 | 292,111 | 285,061 | 278,323 | 271,048 | 268,706 | 266,041 | 263,795 | 261,885 | 256,776 | 244,311 | 226,991 | 210,482 | 194,579 | 188,546 | 187,242 |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 29,292 | 29,081 |
| Operating Expenses | - | - | - | - | - | 38,094 | 37,490 | - | - | 35,016 | 34,748 | - | 34,356 | 34,480 | 33,854 | 33,541 | 31,500 | 27,880 | 24,705 | 21,368 | 19,332 | 18,984 |
| EBITDA | -100.0% | - | 12,235 | 12,347 | 10,745 | 17,460 | 17,269 | 17,435 | 14,277 | 14,047 | 14,366 | 14,211 | 15,205 | 15,526 | 13,362 | 13,368 | - | - | - | - | - | - |
| EBITDA Margin | -100.0% | - | 0.04* | 0.04* | 0.03* | 0.06* | 0.06* | 0.06* | 0.05* | 0.05* | 0.05* | 0.05* | 0.06* | 0.06* | 0.05* | 0.05* | - | - | - | - | - | - |
| Interest Expenses | 4.5% | 2,393 | 2,290 | 2,287 | 2,343 | 2,379 | 2,432 | 2,503 | 2,573 | 2,702 | 2,831 | 2,907 | 2,963 | 2,979 | 2,986 | 3,035 | 3,034 | 2,961 | 2,878 | 2,619 | 3,692 | 2,773 |
| Earnings Before Taxes | -26.6% | 4,310 | 5,869 | 5,836 | 4,361 | 10,962 | 10,568 | 10,537 | 10,075 | 9,736 | 9,961 | 9,770 | 10,879 | 11,206 | 9,837 | 8,997 | 6,765 | 6,531 | 1,875 | 1,406 | 4,113 | 4,276 |
| EBT Margin | -100.0% | - | 0.02* | 0.02* | 0.01* | 0.03* | 0.03* | 0.04* | 0.04* | 0.03* | 0.04* | 0.04* | 0.04* | 0.04* | 0.04* | 0.04* | - | - | - | - | - | - |
| Net Income | -26.7% | 3,091 | 4,219 | 4,311 | 3,365 | 8,379 | 8,141 | 8,001 | 7,586 | 7,212 | 7,407 | 7,179 | 7,969 | 8,275 | 7,225 | 6,634 | 4,468 | 4,328 | -171 | -594 | 3,112 | 3,007 |
| Net Income Margin | -100.0% | - | 0.01* | 0.01* | 0.01* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | - | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 17,392 | 13,450 | 19,498 | 15,868 | 16,194 | 15,745 | 15,191 | 11,618 | 12,928 | 13,428 | 12,641 | 13,628 | 11,722 | 10,391 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 4.5% | 250,071 | 239,330 | 228,275 | 231,212 | 230,279 | 232,873 | 233,052 | 234,891 | 231,164 | 229,606 | 230,715 | 232,898 | 235,495 | 230,639 | 222,449 | 220,113 | 218,904 | 219,768 | 196,456 | 131,506 | 133,290 |
| Current Assets | -1.4% | 67,756 | 68,706 | 65,633 | 68,341 | 62,142 | 61,483 | 60,035 | 60,842 | 56,559 | 55,719 | 56,369 | 59,211 | 62,506 | 58,958 | 50,302 | 48,185 | 46,901 | 47,857 | 45,243 | 71,981 | 73,790 |
| Cash Equivalents | -5.5% | 13,807 | 14,618 | 12,945 | 17,197 | 12,463 | 11,611 | 12,691 | 9,826 | 7,119 | 5,598 | 7,854 | 9,532 | 15,145 | 10,337 | 8,408 | 5,469 | 6,338 | 6,168 | 6,553 | 41,827 | 44,057 |
| Inventory | -5.3% | 17,291 | 18,263 | 19,090 | 18,058 | 17,375 | 18,160 | 17,760 | 17,399 | 16,979 | 17,618 | 18,496 | 17,478 | 16,519 | 16,976 | 17,516 | 16,028 | 15,511 | 15,448 | 16,450 | 14,818 | 14,922 |
| Net PPE | 1.0% | 13,001 | 12,872 | 12,873 | 12,626 | 12,764 | 12,844 | 12,896 | 12,771 | 12,664 | 12,611 | 12,606 | 12,349 | 12,221 | 12,146 | 12,044 | 11,651 | 11,483 | 11,348 | 11,349 | 10,419 | 10,249 |
| Goodwill | 1442.3% | 91,260 | 5,917 | 78,150 | 78,086 | 78,560 | 79,060 | 79,121 | 79,121 | 79,552 | 79,552 | 79,552 | 79,579 | 80,057 | 79,993 | 79,749 | 79,548 | 79,485 | 79,075 | 78,678 | 34,216 | 34,220 |
| Liabilities | 5.6% | 177,069 | 167,750 | 156,506 | 160,201 | 154,773 | 158,733 | 158,211 | 160,273 | 157,599 | 158,442 | 161,014 | 163,786 | 167,140 | 165,165 | 158,279 | 157,180 | 157,305 | 159,762 | 137,913 | 94,884 | 97,679 |
| Current Liabilities | 5.5% | 79,206 | 75,054 | 69,421 | 72,409 | 68,457 | 69,780 | 67,719 | 64,709 | 59,311 | 60,104 | 62,017 | 62,044 | 63,694 | 59,560 | 53,303 | 52,544 | 49,376 | 50,631 | 45,762 | 29,460 | 31,493 |
| Short Term Borrowings | - | 1,000 | - | - | - | - | - | - | - | - | 252 | - | - | - | 255 | - | 1,070 | 446 | 3,005 | 720 | - | - |
| Long Term Debt | 8.8% | 61,419 | 56,450 | 50,476 | 50,848 | 50,797 | 52,063 | 51,971 | 56,832 | 59,294 | 59,270 | 59,207 | 61,552 | - | - | 64,699 | - | - | - | 71,444 | - | - |
| LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,192 | 5,828 | 3,781 | 3,778 | 3,894 | 3,893 | 1,265 | 2,139 | 3,540 |
| LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | 63,481 | 65,735 | 64,699 | 64,206 | 66,941 | 67,888 | 71,444 | 60,747 | 61,569 |
| Shareholder's Equity | 1.6% | 72,726 | 71,580 | 71,469 | 70,683 | 75,736 | 74,034 | 75,381 | 74,618 | 73,565 | 71,164 | 69,701 | 69,112 | 68,355 | 65,474 | 64,170 | 62,933 | 61,599 | 60,006 | 58,543 | 36,622 | 35,611 |
| Retained Earnings | 1.9% | 58,868 | 57,753 | 56,398 | 54,571 | 58,710 | 56,488 | 54,997 | 54,264 | 53,331 | 51,203 | 49,640 | 49,328 | 48,768 | 46,455 | 45,108 | 44,017 | 43,136 | 41,859 | 40,911 | 41,843 | 40,965 |
| Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 32,360 | 32,264 |
| Shares Outstanding | 0.2% | 1,282 | 1,279 | 1,300 | 1,315 | 1,313 | 1,312 | 1,322 | 1,321 | 1,319 | 1,313 | 1,310 | 1,310 | 1,309 | 1,306 | 1,302 | 1,302 | 1,301 | 1,298 | 1,295 | 1,020 | 1,018 |
| Minority Interest | 39.4% | 276 | 198 | 300 | 328 | 322 | 310 | 306 | 310 | 321 | 314 | 312 | 305 | 333 | 334 | 306 | 319 | 317 | 320 | 318 | 4.00 | 4.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | 2.3% | 20,517 | 20,052 | 16,177 | 22,134 | 18,532 | 18,936 | 18,265 | 17,827 | 14,180 | 15,452 | 15,865 | 14,932 | 15,986 | 14,205 | 12,848 | 12,693 | 10,862 | 8,458 | 8,865 | 6,250 | 7,764 |
| Share Based Compensation | 12.4% | 518 | 461 | 447 | 479 | 488 | 486 | 484 | 458 | 453 | 391 | 400 | 386 | 406 | 435 | 453 | 463 | 396 | 339 | 280 | 233 | 236 |
| Cashflow From Investing | -71.2% | -19,800 | -11,568 | -5,047 | -6,368 | -6,410 | -5,387 | -5,261 | -5,055 | -5,578 | -5,804 | -5,534 | -5,009 | -4,468 | -4,045 | -3,339 | -44,529 | -44,334 | -44,045 | -43,285 | -2,696 | -2,495 |
| Cashflow From Financing | 118.4% | 947 | -5,140 | -10,516 | -11,243 | -9,955 | -10,821 | -11,356 | -11,718 | -15,905 | -13,556 | -7,696 | -5,664 | -2,515 | -5,795 | -7,654 | -4,518 | -4,243 | -505 | 36,819 | 35,597 | 36,504 |
| Dividend Payments | 1.9% | 3,019 | 2,964 | 2,907 | 2,848 | 2,781 | 2,691 | 2,625 | 2,609 | 2,615 | 2,628 | 2,624 | 2,631 | 2,612 | 2,606 | 2,603 | 2,462 | 2,326 | 2,179 | 2,038 | 2,038 | 2,039 |
| Buy Backs | -0.1% | 3,516 | 3,518 | 3,500 | 2,000 | 2,000 | 2,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CVS Income Statement
2023-06-30Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Revenues: | ||||
| Premiums | $ 25,108 | $ 21,260 | $ 49,460 | $ 42,891 |
| Net investment income | 274 | 146 | 608 | 314 |
| Total revenues | 88,921 | 80,636 | 174,199 | 157,462 |
| Operating costs: | ||||
| Cost of products sold | 53,536 | 49,290 | 104,991 | 94,799 |
| Health care costs | 21,782 | 17,490 | 42,230 | 35,413 |
| Restructuring charge | 496 | 0 | 496 | 0 |
| Opioid litigation charge | 0 | 0 | 0 | 484 |
| Loss on assets held for sale | 0 | 0 | 349 | 41 |
| Operating expenses | 9,873 | 9,187 | 19,453 | 18,511 |
| Total operating costs | 85,687 | 75,967 | 167,519 | 149,248 |
| Operating income | 3,234 | 4,669 | 6,680 | 8,214 |
| Interest expense | 686 | 583 | 1,275 | 1,169 |
| Other income | (22) | (43) | (44) | (85) |
| Income before income tax provision | 2,570 | 4,129 | 5,449 | 7,130 |
| Income tax provision | 656 | 1,090 | 1,393 | 1,736 |
| Net income | 1,914 | 3,039 | 4,056 | 5,394 |
| Net income attributable to noncontrolling interests | (13) | (10) | (19) | (11) |
| Net income attributable to CVS Health | $ 1,901 | $ 3,029 | $ 4,037 | $ 5,383 |
| Net income per share attributable to CVS Health: | ||||
| Basic (in dollars per share) | $ 1.48 | $ 2.31 | $ 3.15 | $ 4.10 |
| Diluted (in dollars per share) | $ 1.48 | $ 2.29 | $ 3.13 | $ 4.06 |
| Weighted average shares outstanding: | ||||
| Basic (in shares) | 1,283 | 1,313 | 1,283 | 1,312 |
| Diluted (in shares) | 1,287 | 1,321 | 1,289 | 1,325 |
| Dividends declared per share (in dollars per share) | $ 0.605 | $ 0.55 | $ 1.21 | $ 1.10 |
| Cost, Product and Service [Extensible List] | Products | Products | Products | Products |
| Products | ||||
| Revenues: | ||||
| Revenues | $ 60,539 | $ 56,794 | $ 118,686 | $ 109,316 |
| Services | ||||
| Revenues: | ||||
| Revenues | $ 3,000 | $ 2,436 | $ 5,445 | $ 4,941 |
CVS Balance Sheet
2023-06-30Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Assets: | ||
| Cash and cash equivalents | $ 13,807 | $ 12,945 |
| Investments | 3,080 | 2,778 |
| Accounts receivable, net | 29,546 | 27,276 |
| Inventories | 17,291 | 19,090 |
| Assets held for sale | 620 | 908 |
| Other current assets | 3,412 | 2,636 |
| Total current assets | 67,756 | 65,633 |
| Long-term investments | 22,114 | 21,096 |
| Property and equipment, net | 13,001 | 12,873 |
| Operating lease right-of-use assets | 17,703 | 17,872 |
| Goodwill | 91,260 | 78,150 |
| Intangible assets, net | 30,118 | 24,803 |
| Separate accounts assets | 3,267 | 3,228 |
| Other assets | 4,852 | 4,620 |
| Total assets | 250,071 | 228,275 |
| Liabilities: | ||
| Accounts payable | 13,367 | 14,838 |
| Pharmacy claims and discounts payable | 20,417 | 19,423 |
| Health care costs payable | 11,998 | 10,142 |
| Policyholders’ funds | 1,411 | 1,500 |
| Accrued expenses | 22,831 | 18,745 |
| Other insurance liabilities | 4,866 | 1,089 |
| Current portion of operating lease liabilities | 1,706 | 1,678 |
| Short-term debt | 1,000 | 0 |
| Current portion of long-term debt | 1,402 | 1,778 |
| Liabilities held for sale | 208 | 228 |
| Total current liabilities | 79,206 | 69,421 |
| Long-term operating lease liabilities | 16,609 | 16,800 |
| Long-term debt | 61,419 | 50,476 |
| Deferred income taxes | 4,588 | 4,016 |
| Separate accounts liabilities | 3,267 | 3,228 |
| Other long-term insurance liabilities | 5,659 | 5,835 |
| Other long-term liabilities | 6,321 | 6,730 |
| Total liabilities | 177,069 | 156,506 |
| Shareholders’ equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | 0 | 0 |
| Common stock, par value $0.01: 3,200 shares authorized; 1,764 shares issued and 1,282 shares outstanding at June 30, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus | 48,649 | 48,193 |
| Treasury stock, at cost: 482 shares at June 30, 2023 and 458 shares at December 31, 2022 | (33,933) | (31,858) |
| Retained earnings | 58,868 | 56,398 |
| Accumulated other comprehensive loss | (858) | (1,264) |
| Total CVS Health shareholders’ equity | 72,726 | 71,469 |
| Noncontrolling interests | 276 | 300 |
| Total shareholders’ equity | 73,002 | 71,769 |
| Total liabilities and shareholders’ equity | $ 250,071 | $ 228,275 |
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.